Brain+ A/S, a healthtech company, develops and commercializes technology solutions in dementia care primarily for cognitive stimulation therapy. The company is developing Ayla, a scalable dementia care platform that offers practical, human-centered, and clinically proven software-based dementia therapy and care solutions. It is also developing Ayla " your CST Assistant, a software-based dementia care platform that offers high-quality and scalable cognitive stimulation therapy (CST). The company offers its products to healthcare providers, as well as patients and carers. Brain+ A/S was incorporated in 2012 and is based in Copenhagen, Denmark.
Frequently asked questions
What sector does Brain+ ApS (BRAINP) operate in?
Brain+ ApS belongs to the Healthcare sector and operates in the Health Information Services industry.
What is Brain+ ApS (BRAINP) current stock price?
As of the latest data, Brain+ ApS stock price is DKK 0.00, with a previous close of DKK 0.00.
What is Brain+ ApS (BRAINP) current market capitalization?
Brain+ ApS market cap is approximately 4.76 million.
What is Brain+ ApS (BRAINP) Earnings Per Share (EPS)?
The trailing EPS is DKK 0.03.
What is Brain+ ApS (BRAINP) Price-to-Earnings (P/E) ratio?
Brain+ ApS current P/E ratio is 0.14.
Does Brain+ ApS (BRAINP) pay dividends?
No. Brain+ ApS does not pay a dividend.
What is Brain+ ApS (BRAINP) beta (volatility) score?
Brain+ ApS has a beta of -0.344, indicating lower volatility than the overall market.
